tranexamic acid has been researched along with Adenocarcinoma in 15 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the present phase II trial, 26 heavily pretreated patients with advanced recurrent ovarian carcinoma were treated with tranexamic acid, 4-6 g per os daily for at least 3 months." | 7.66 | Tranexamic acid for the treatment of advanced ovarian carcinoma. ( Johnsson, JE; Sigurdsson, K; Tropé, C, 1983) |
| " pentoxifylline (Px) (which also were found to release PgI2 and t-PA) inhibited human tumor implant induced angiogenesis and reduced spontaneous metastases in 3 transplantable murine tumors (Furth-Columbia Wilms' tumor in Furth-Wistar rats, C-1300 neuroblastoma in A/J mice and HM-Kim mammary carcinoma in Wistar rats) but not in the NIH adenocarcinoma in Balb/c mice." | 3.68 | Studies on tumor induced angiogenesis. ( Ambrus, CM; Ambrus, JL; Forgach, P; Halpern, J; Niswander, P; Sayyid, S; Stadler, S; Toumbis, C, 1992) |
| "In the present phase II trial, 26 heavily pretreated patients with advanced recurrent ovarian carcinoma were treated with tranexamic acid, 4-6 g per os daily for at least 3 months." | 3.66 | Tranexamic acid for the treatment of advanced ovarian carcinoma. ( Johnsson, JE; Sigurdsson, K; Tropé, C, 1983) |
| "The fibrinolytic inhibitor tranexamic acid affects certain experimental tumours; it prolongs survival (Lewis lung adenocarcinoma), decreases tumour weight (C3H breast carcinoma), and inhibits ascitic production (AH 130 rat hepatoma)." | 3.66 | Effect of tranexamic acid on progress of experimental tumours and on DNA-synthesis. ( Astedt, B; Tropé, C, 1980) |
| "Fibrinogen level was normalized within two days (2." | 1.43 | Primary hyperfibrinolysis as the presenting sign of prostate cancer: A case report. ( Cvetković, Z; Kulić, A; Libek, V, 2016) |
| "Two of them, including our case, had gastric cancer." | 1.27 | Cronkhite-canada syndrome associated with gastric cancer: report of a case. ( Fujiyama, S; Kamuro, Y; Sagara, K; Sato, T; Tashiro, A, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (40.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kulić, A | 1 |
| Cvetković, Z | 1 |
| Libek, V | 1 |
| Schwameis, M | 1 |
| Thaler, J | 1 |
| Schober, A | 1 |
| Schörgenhofer, C | 1 |
| Kulinna-Cosentini, C | 1 |
| Laggner, A | 1 |
| Röggla, M | 1 |
| Jilma, B | 1 |
| Huang, GC | 1 |
| Chen, LJ | 1 |
| Liu, HC | 1 |
| Chen, YJ | 1 |
| Fuentes García, D | 1 |
| Ramírez Muñoz, G | 1 |
| Sajdak, S | 1 |
| Moszynski, R | 1 |
| Opala, T | 1 |
| Yeh, HM | 1 |
| Lau, HP | 1 |
| Lin, PL | 1 |
| Sun, WZ | 1 |
| Mok, MS | 1 |
| Hodson, A | 1 |
| Hunt, BJ | 1 |
| Sigurdsson, K | 1 |
| Johnsson, JE | 1 |
| Tropé, C | 2 |
| Sagara, K | 1 |
| Fujiyama, S | 1 |
| Kamuro, Y | 1 |
| Tashiro, A | 1 |
| Sato, T | 1 |
| Astedt, B | 2 |
| Meijer, K | 1 |
| Smid, WM | 1 |
| Geerards, S | 1 |
| van der Meer, J | 1 |
| Rutqvist, LE | 1 |
| Bolund, C | 1 |
| Friberg, S | 1 |
| Einhorn, N | 1 |
| Wallgren, A | 1 |
| Ambrus, JL | 1 |
| Ambrus, CM | 1 |
| Forgach, P | 1 |
| Stadler, S | 1 |
| Halpern, J | 1 |
| Sayyid, S | 1 |
| Niswander, P | 1 |
| Toumbis, C | 1 |
| Kikuchi, Y | 1 |
| Kizawa, I | 1 |
| Oomori, K | 1 |
| Kuki, E | 1 |
| Kato, K | 1 |
15 other studies available for tranexamic acid and Adenocarcinoma
| Article | Year |
|---|---|
Primary hyperfibrinolysis as the presenting sign of prostate cancer: A case report.
Topics: Adenocarcinoma; Antifibrinolytic Agents; Biomarkers; Blood Coagulation Disorders; Blood Coagulation | 2016 |
Tranexamic acid and fibrinogen restore clotting in vitro and in vivo in cardiac thrombus associated hyperfibrinolysis with overt bleedings.
Topics: Adenocarcinoma; Aged; Anemia; Antifibrinolytic Agents; Antineoplastic Combined Chemotherapy Protocol | 2014 |
Development of vitreous haemorrhage during treatment with bevacizumab for metastatic rectal cancer.
Topics: Adenocarcinoma; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Human | 2008 |
[Type A hemophilia in a man undergoing liver resection for metastasis: implications for anesthetic management].
Topics: Adenocarcinoma; Aged; Anesthesia, General; Blood Loss, Surgical; Colorectal Neoplasms; Deamino Argin | 2009 |
Bleeding from endometrial and vaginal malignant tumors treated with activated recombinant factor VII.
Topics: Adenocarcinoma; Administration, Intravaginal; Adult; Aged; Endometrial Neoplasms; Ethamsylate; Facto | 2002 |
Convulsions and refractory ventricular fibrillation after intrathecal injection of a massive dose of tranexamic acid.
Topics: Adenocarcinoma; Aged; Antifibrinolytic Agents; Cardiopulmonary Resuscitation; Drug Overdose; Fatal O | 2003 |
A bleeding tongue - acute presentation of fibrinolysis.
Topics: Adenocarcinoma; Aged; Antifibrinolytic Agents; Fibrinolysis; Hemorrhage; Humans; Male; Prostatic Neo | 2007 |
Tranexamic acid for the treatment of advanced ovarian carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Carcinoma; Cyclohexanecarboxylic Acids; Drug | 1983 |
Cronkhite-canada syndrome associated with gastric cancer: report of a case.
Topics: Adenocarcinoma; Aged; Food, Formulated; Humans; Intestinal Polyps; Male; Pigmentation Disorders; Sto | 1983 |
Adjuvant treatment of ovarian carcinoma with tranexamic acid.
Topics: Adenocarcinoma; Cyclohexanecarboxylic Acids; Cystadenoma; Female; Humans; Ovarian Neoplasms; Plasmin | 1980 |
Effect of tranexamic acid on progress of experimental tumours and on DNA-synthesis.
Topics: Adenocarcinoma; Animals; Cyclohexanecarboxylic Acids; DNA, Neoplasm; Liver Neoplasms, Experimental; | 1980 |
Hyperfibrinogenolysis in disseminated adenocarcinoma.
Topics: Adenocarcinoma; Adult; Afibrinogenemia; alpha-2-Antiplasmin; Antifibrinolytic Agents; Brain Ischemia | 1998 |
[Treatment of advanced cancer with Cyclocapron (tranexamic acid)].
Topics: Adenocarcinoma; Adult; Aged; Breast Neoplasms; Cyclohexanecarboxylic Acids; Female; Humans; Melanoma | 1977 |
Studies on tumor induced angiogenesis.
Topics: Adenocarcinoma; Aminocaproic Acid; Animals; Cornea; Ditiocarb; Humans; Kidney Neoplasms; Macaca; Mam | 1992 |
The inhibitory effect of tranexamic acid on human ovarian carcinoma cell grown in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Carcinoma, Squamous Cell; Cell Line; Colony-Forming Units Assay; Cyclohexan | 1986 |